In the healthcare industry of the United States, American Physicians are not in good terms with the American Board of Internal Medicine (ABIM), who according to reports, continue to increase recertification fees.
The NeurologyAdvisor, yesterday posted about Physicians challenging ABIM with grassroots Recertification efforts, a battle that has been brewing for quite some time between physicians and the American Board of Internal Medicine, which is coming to a head in the form of a new medical recertification organization called the National Board of Physicians and Surgeons. See below for more information on this trending issue, and leave a comment afterwards to share your thoughts.
The new organization is a direct result of mounting frustration among medical professionals who claim the American Board of Internal Medicine (ABIM) has been implementing sky-high fees and altering recertification exams to the point that pass rates across specialties have steadily declined over the last few years.
Frustrated by the deteriorating relationship, a group of prominent physicians led by Scripps Clinic chief of cardiology Paul Teirstein, MD, have formed the new recertification organization — a grassroots effort that requires physicians to lobby their hospital administrators and insurance companies to accept recertification qualifications under the new organization.
Beyond mounting fees and exorbitant ABIM chair-person salaries, physicians seem to be most perplexed by changes made to recertification exams that force specialized physicians to learn protocols and skills not directly associated with their clinical practice. For example, an anesthesiologist that only treats adults would have to learn proper dosing administration for pediatric patients — a skill set that is not required as an adult-only physician and one that requires a great deal of knowledge outside clinical expectations.
What remains unknown is whether hospitals administrators, insurers, and colleagues will be open to accepting credentials from what is currently a relatively unknown entity.